Major Depressive Disorder Market Growth, Trends, and Key Insights | Global Forecast 2025-2033 | Leading key players - eva Pharmaceutical Industries Ltd., Viatris Inc.

The Global Major Depressive Disorder Market size reached US$ 6.84 billion in 2024 and is expected to reach US$ 14.57 billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.

Major Depressive Disorder Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/major-depressive-disorder-market?sz

The Major Depressive Disorder (MDD) market focuses on the diagnosis, treatment, and management of depression, a mental health condition affecting millions worldwide. This market includes therapies such as antidepressants, psychotherapy, and emerging treatments like neuromodulation. With growing awareness and advancements in personalized medicine, the MDD market aims to improve patient outcomes and reduce the global mental health burden.

List of the Key Players in the Major Depressive Disorder Market:

Pfizer Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Otsuka Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Sanofi, Biogen, among Others.

Industry Development:

In April 2025, MindMed announced that the first patient had been dosed in its Phase 3 Emerge study, which is investigating MM120 ODT for the treatment of major depressive disorder (MDD). MM120 ODT is a proprietary, pharmaceutically refined formulation of lysergic acid diethylamide (LSD), developed to optimize its therapeutic potential in treating mental health conditions like depression. This study marks a significant milestone for the company in the development of psychedelic-assisted therapies.

In March 2025, Neuronetics, Inc. announced that Evernorth Health Services, a wholly owned subsidiary of The Cigna Group, expanded its coverage of NeuroStar Transcranial Magnetic Stimulation (TMS) to include adolescents aged 15 and older living with major depressive disorder (MDD). This expansion broadens access to non-invasive neuromodulation therapy, offering an alternative treatment option for younger patients struggling with MDD.

Growth Forecast Projected:

The Global Major Depressive Disorder Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Major Depressive Disorder Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/major-depressive-disorder-market

Segment Covered in the Major Depressive Disorder Market:

By Type: Seasonal Affective Disorder, Prenatal Depression, Postpartum Depression, Atypical Depression.

By Treatment Type: Antidepressants, Psychotherapy, Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Vagus Nerve Stimulation (VNS), Others.

Regional Analysis for Major Depressive Disorder Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/major-depressive-disorder-market

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Major Depressive Disorder market?

➠ Who are the leading manufacturers in the global Major Depressive Disorder industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Major Depressive Disorder industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Major Depressive Disorder market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/major-depressive-disorder-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.